Do media reports and public brochures facilitate informed decision making about cervical cancer prevention?;Ermöglichen Medienberichte und Broschüren informierte Entscheidungen zur Gebärmutterhalskrebsprävention?

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 54, Issue 11, 2011, Pages 1197-1210

  Neumeyer Gromen, A ^a   Bodemer, N ^a   Muller S M ^b   Gigerenzer, G ^a  

^a MAX PLANCK INSTITUTE FOR HUMAN DEVELOPMENT   (Germany)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Cervical cancer; Facts box; HPV vaccination; Media analysis; Pap screening

Indexed keywords

HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CHILD; DECISION MAKING; FEMALE; GERMANY; HEALTH EDUCATION; HUMAN; MASS MEDIUM; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PUBLICATION; RISK REDUCTION; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADOLESCENT; ADULT; CHILD; DECISION MAKING; FEMALE; GERMANY; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MASS MEDIA; PAMPHLETS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; RISK REDUCTION BEHAVIOR; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 81855212511     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-011-1347-5     Document Type: Article

References (54)

1. Cassells A, Hughs M, Cole C et al (2003) Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs. CMAJ 168:1133-1137 (Pubitemid 36543224)
2. Moynihan R, Bero L, Ross-Degnan D et al (2000) Coverage by the news media of the benefits and risks of medications. N Engl J Med 342:1645-1650 (Pubitemid 30341535)
3. Schwartz LM, Woloshin S, Welch HG (1999) Misunderstandings about the effects of race and sex on physicians referrals for cardiac catheterization. N Engl J Med 341:279-283
4. Steckelberg A, Balgenorth A, Mühlhauser I (2001) Analyse von deutschsprachigen Verbraucher-Informationsbroschüren zum Screening auf kolorektales Karzinom. Z Evid Fortbild Qual Gesundhwes 95:535-538 (Pubitemid 33710734)
5. Woloshin S, Schwartz LM (2006) Media reporting of research presented at scientific meetings: more caution needed. Med J 184:576-580 (Pubitemid 43950029)
6. Gigerenzer G (2002) Reckoning with risk: Learning to live with uncertainty. Penguin Books, London
7. Gigerenzer G, Gaissmaier W, Kurz-Milcke E et al (2007) Helping doctors and patients make sense of health statistics. Psychol Sci Public Interest 2:53-95
8. Neumeyer-Gromen A, Bräunlich A, Zeeb H, Razum O (2006) Theorie und Praxis der Epidemiologie Teil I: Systematik theoretischer Grundlagen der Epidemiologie als zentrale Fachdisziplin von Public Health. Prävention Gesundheitsförderung 3:190-197 (Pubitemid 44735221)
9. Gøtzsche PC, Nielsen M (2009) Screening for breast cancer with mammography. Cochrane Database Syst Rev 4:CD001877
10. Neumeyer-Gromen A, Gaissmaier W (2009) Screening Programs. In: Kattan MW (Hrsg) Encyclopedia of medical decision making. Sage, Cleveland Ohio
11. Higgins JPT, Green S (Hrsg) (2008) Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008]. The Cochrane Collaboration. http://www.cochrane.org/resources/handbook/index.htm oder http://www.cochrane-handbook.org
12. Schwartz LM, Woloshin S, Welch HG (2007) The drug facts box: providing consumers with simple tabular data on drug benefit and harm. Med Decis Making 27:655-662 (Pubitemid 47547602)
13. Wentzensen N, Klug SJ (2009) Früherkennung des Zervixkarzinoms: Suche nach einem Gesamtkonzept. Dtsch Arztebl 105:617-622
14. Munoz N, Bosch X, de Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348(6):518-527 (Pubitemid 36159887)
15. Schiffman M (2007) Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer 111:145-153 (Pubitemid 46982691)
16. Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 12:186-192 (Pubitemid 23095196)
17. Mühlhauser I, Filz M (2008) Screening auf Zervixkarzinom. a-t 39:29-38
18. Winer RL, Hughes JP, Feng Q et al (2006) Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 354(25):2645-2654
19. Robert Koch-Institut/RKI (2007) Mitteilung der Ständigen Impfkommission/STIKO am RKI (Stand: März 2007). Epidemiol Bull 12:97-103
20. Statistisches Bundesamt (2009) Gesundheitsberichterstattung des Bundes (2009). http://www.destatis.de
21. FUTURE II Study Grp (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356:1915-1927
22. FUTURE I investigators (2007) Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356:1928-1943
23. European Medicine Agency/EMA 2008) Europ. Beurteilungsbericht (EPAR) GARDASIL (31/10/2008 Gardasil-H-C-703- II-13). http://www.ema.europa.eu/ema/ index.jsp?curl=pages/medicines/human/medicines/000703/human-med-000805. jsp&mid=WC0b01ac058001d125&murl=menus/medicines/medicines.jsp und http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Procedural-steps- taken-and-scientific-information-after-authorisation/human/000703/WC500021147. pdf
24. Löwer J, Stöcker S (2009) Paul-Ehrlich-Institut: Wie wirksam ist die HPV-Impfung? Dtsch Arztebl 106:386-388
25. Centers for Disease Control and Prevention (CDC) (2008) Vaccine Adverse Event Reporting System (VAERS) 2008. http://www.vaers.hhs.gov/scripts/data.cfm
26. a-t (Arznei-Telegramm) (2008) 1997 und 2007 im Vergleich - die Umsatzstärksten Arzneimittel. a-t 39:65-66
27. Rosenbrock R (2007) HPV-Impfung - Durchbruch in der Krebsprävention? http://www.forum-gesundheitspolitik.de/artikel/artikel.pl?artikel=0644 oder http://www.forum-gesundheitspolitik.de/dossier/PDF/Rosenbrock-HPV-Impfung.pdf
28. Voß KD (2007) Prävention als Aufgabe der Gesundheitspolitik - Anforderungen an die Gesetzliche Krankenversicherung. http://www. gesundheitberlin.de/download/Vo %DF-2.pdf
29. Zechmeister I, Freiesleben de Blasio B, Radlberger P et al (2007) Ökonomische Evaluation der Impfung gegen humane Papillomaviren (HPV-Impfung) in Österreich. HTA-Projektbericht Nr. 009, Wien 2007. http://eprints.hta.lbg.ac.at/760/2/HTA-Projektbericht-009.pdf
30. European Medicine Agency/EMA (2010) Gardasil: EPAR - Summary for the public (14/09/2010) http://www.ema.europa.eu/docs/en-GB/document-library/EPAR- Summary-for-the-public/human/000703/WC500021146.pdf und http://www.ema.europa. eu/docs/en-GB/document-library/EPAR-Procedural-steps-taken-and-scientific- information-after-authorisation/human/000703/WC500021147.pdf
31. Robert Koch-Institut/RKI (2010) Empfehlungen der Ständigen Impfkommission/STIKO am RKI/Stand Juli 2010 Epidemiol Bull 30:235-250
32. Siebert U, Muth C, Sroczynski G et al (2003) Dünnschichtprä parationen und computergestützte Untersuchungen von Zervixabstrichen. Asgard, St. Augustin. http://gripsdb.dimdi.de/de/hta/hta-berichte/hta067- bericht-de.pdf
33. Siebert U, Sroczynski G, Hillemanns P et al (2006) The German Cervical Cancer Screening Model: development and validation of a decision-analytic model for cervical cancer screening in Germany. Eur J Public Health 16:185-192
34. Coste J, Cochand-Priollet B, Cremoux P de (2003) Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening. BMJ 7392:733A-736A
35. Petry KU, Breugelmans JG, Benard S et al (2008) Cost of screening and treatment of cervical dyscaryosis in Germany. Eur J Gynaecol Oncol 29:345-349
36. Schneider A, Schwarz TF, Hammerschmidt T et al (2007) Treatment patterns and costs of unclear and abnormal cervical conditions in Germany. Geburtsh Frauenheilkd 67:859-865 (Pubitemid 47571557)
37. Merten K (1995) Inhaltsanalyse. Einführung in Theorie, Methode und Praxis. Westdeutscher Verlag, Opladen
38. Cuzick J, Clavel C, Petry KU et al (2006) Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119:1095-1101 (Pubitemid 44116919)
39. Schneider A, Hoyer H, Lotz B et al (2000) Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 89:529-534
40. Petry KU, Menton S, Menton M et al (2003) Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 88:1570-1577 (Pubitemid 36713784)
41. Grouven U, Bender R, Ziegler A, Lange S (2007) Der Kappa-Koeffizient. Dtsch Med Wochenschr 132:e65-e68
42. Gerhardus A, Razum O (2010) A long story made too short: surrogate variables and the communication of HPV vaccine trial results. J Epidemiol Community Health 64:377-378
43. Kurzenhäuser S (2003) What kind of information do German health information pamphlets provide on mammography screening? Z Arztl Fortbild Qualitatssich 97:53-57 (Pubitemid 36331175)
44. Gigerenzer G, Gray JAM (2011) Launching the century of the patient. In: Gigerenzer G, Muir JAM (Hrsg) Better doctors, better patients, better decisions: envisioning health care 2020. Strüngmann Forum Report, Bd 6. MIT, Cambridge, MA
45. Gigerenzer G, Mata J, Frank R (2009) Public knowledge of benefits of breast and prostate cancer screening in Europe. J Natl Cancer Inst 101:1216-1220
46. Schiffman M, Castle PE, Jeronimo J et al (2007) Human papillomavirus and cervical cancer. Lancet 370:890-907 (Pubitemid 47371147)
47. Gerhardus A, Dören M, Gerlach FM et al (2009) Gebä rmutterhalskrebs: Wie wirksam ist die HPV-Impfung? Dtsch Arztebl 106:330-334
48. Kristensen FB, Gerhardus A (2010) Health technology assessments: What do differing conclusions tell us? BMJ 341:c5236
49. Strobe-Statement (2007) Strengthening the reporting of observational studies in epidemiology. http://www.strobe-statement.org/
50. Elwyn GJ, OConnor A, Stacey D et al (2006) Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. BMJ 333(7565):417-424
51. Holmes-Rovner M (2007) International Patient Decision Aid Standards (IPDAS) beyond decision aids to usual design of patient education materials. Health Expect 10(2):103-107 (Pubitemid 46808896)
52. OConnor AM, Bennett CL, Stacey D et al (2009) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev (3):CD001431
53. WHO (2010) Health information for patients and the general public produced by the German Institute for Quality and Efficiency in Health Care. A review by the World Health Organization 2008/2009. http://www.euro.who.int/- data/assets/pdf-file/0012/94989/E93735.pdf
54. Neumeyer-Gromen A, Lampert T, Stark K, Kallischnigg G (2004) Disease management programs for depression - a systematic review and meta-analysis of randomized controlled trials. Med Care 42:1211-1221 (Pubitemid 39627298)